F500-0143 Screening compound: N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-1,3,4-thiadiazole-2-carboxamide

F500-0143 Screening compound: N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-1,3,4-thiadiazole-2-carboxamide
F500-0143 Screening compound: N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F500-0143
N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F500-0143

Molecular Formula

C21H24N4O4S2 (C21 H24 N4 O4 S2)

Compound Name

N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-1,3,4-thiadiazole-2-carboxamide

IUPAC name

N-(4-methoxyphenyl)-5-[({[2-methyl-1-(thiophen-2-yl)propyl]carbamoyl}methoxy)methyl]-134-thiadiazole-2-carboxamide

SMILES

CC(C)C(c1cccs1)NC(COCc1nnc(C(Nc(cc2)ccc2OC)=O)s1)=O

InChI

InChI=1S/C21H24N4O4S2/c1-13(2)19(16-5-4-10-30-16)23-17(26)11-29-12-18-24-25-21(31-18)20(27)22-14-6-8-15(28-3)9-7-14/h4-10,13,19H,11-12H2,1-3H3,(H,22,27)(H,23,26)/t19-/m0/s1

InChI Key

GLHVABCDNJMBRP-IBGZPJMESA-N

MDL Number (MFCD)

MFCD14956488

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.044

Distribution Coefficient, logD

3.044

Water Solubility, LogSw

-3.58

Polar Surface Area

87.877

Acid Dissociation Constant (pKa)

11.08

Base Dissociation Constant (pKb)

-0.43

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

F500-0143 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F500-0143 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F500-0143?
Check Price and Availability of F500-0143, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F500-0143 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F500-0143
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F500-0143
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F500-0143 available by request